Impact of Dementia on Mortality Due to Coronavirus Disease 2019: Propensity-Score-Matching Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Patients with dementia are particularly vulnerable to coronavirus disease 2019 (COVID-19) because they tend to be older and often have concomitant diseases. Previous studies have investigated the impact of dementia on COVID-19 outcomes, but the evidence is not robust for Asian populations. We aimed to determine the relationship between dementia and COVID-19 outcomes using data from a large-scale nationwide public database. Methods Data on patients with COVID-19 who were released from quarantine between January 1, 2020 and April 30, 2020, published by the Korea Disease Control and Prevention Agency, were divided into two groups based on the dementia status. Propensity-score matching was used to adjust for multiple confounders between the dementia and no-dementia groups. Binary, ordinal logistic regression and multivariate Cox proportional-hazards models were used to compare mortality, quarantine duration, and clinical deterioration according to the dementia status in the two groups. Results Males and older individuals (age ≥60 years) constituted 41.5% and 32.9%, respectively, of the 5,299 patients. The prevalence of dementia was 4.2%, and 4.5% of the participants died during hospitalization. In multivariate analysis, dementia was significantly associated with increased mortality (odds ratio [OR]=2.80, 95% confidence interval [CI]=1.60–4.60), longer duration of quarantine (hazard ratio=1.69, 95% CI=1.16–2.45), and larger shift to a worse clinical severity (common OR=1.74, 95% CI=1.18–2.61). Conclusions After adjusting for important clinical predictors, dementia was associated with increased in-hospital mortality, duration of quarantine, and clinical deterioration during hospitalization in COVID-19 patients.
Abstract
Background and Purpose Patients with dementia are particularly vulnerable to coronavirus disease 2019 (COVID-19) because they tend to be older and often have concomitant diseases. Previous studies have investigated the impact of dementia on COVID-19 outcomes, but the evidence is not robust for Asian populations. We aimed to determine the relationship between dementia and COVID-19 outcomes using data from a large-scale nationwide public database. Methods Data on patients with COVID-19 who were released from quarantine between January 1, 2020 and April 30, 2020, published by the Korea Disease Control and Prevention Agency, were divided into two groups based on the dementia status. Propensity-score matching was used to adjust for multiple confounders between the dementia and no-dementia groups. Binary, ordinal logistic regression and multivariate Cox proportional-hazards models were used to compare mortality, quarantine duration, and clinical deterioration according to the dementia status in the two groups. Results Males and older individuals (age ≥60 years) constituted 41.5% and 32.9%, respectively, of the 5,299 patients. The prevalence of dementia was 4.2%, and 4.5% of the participants died during hospitalization. In multivariate analysis, dementia was significantly associated with increased mortality (odds ratio [OR]=2.80, 95% confidence interval [CI]=1.60–4.60), longer duration of quarantine (hazard ratio=1.69, 95% CI=1.16–2.45), and larger shift to a worse clinical severity (common OR=1.74, 95% CI=1.18–2.61). Conclusions After adjusting for important clinical predictors, dementia was associated with increased in-hospital mortality, duration of quarantine, and clinical deterioration during hospitalization in COVID-19 patients.
참고문헌 (27)
- Jin Yong Kim, "The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures", Journal of Korean Medical Science, 35(5), pp.1~4 (2020), 대한의학회[DOI]
- "Population-level mortality rates from novel coronavirus(COVID-19)in South Korea"[URL]
- Hariyanto TI, "Dementia and outcomes from coronavirus disease 2019(COVID-19)pneumonia : a systematic review and meta-analysis", Arch Gerontol Geriatr, 93, pp.104299~ (2020)
- Nayoung Ryoo, "Coping with Dementia in the Middle of the COVID-19 Pandemic", Journal of Korean Medical Science, 35(42), pp.1~21 (2020), 대한의학회[DOI]
- Bauer K, "A claims data-based comparison of comorbidity in individuals with and without dementia", BMC Geriatr, 14, pp.10~ (2014)
- Docherty AB, "Features of 20133 UK patients in hospital with covid-19using the ISARIC WHO clinical characterisation protocol : prospective observational cohort study", BMJ, 369, pp.m1985~ (2020)
- Bianchetti A, "Clinical presentation of COVID19 in dementia patients", J Nutr Health Aging, 24, pp.560~562 (2020)
- Hwang JM, "Neurological diseases as mortality predictive factors for patients with COVID-19 : a retrospective cohort study", Neurol Sci, 41, pp.2317~2324 (2020)
- 문성수, "Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals", Journal of Korean Medical Science, 35(36), pp.1~10 (2020), 대한의학회[DOI]
- Jin J, "Individual and community-level risk for COVID-19 mortality in the United States", Nat Med, 27, pp.264~269 (2020)
- Hummer RA, "Critical Perspectives on Racial and Ethnic Differences in Health in Late Life", pp.53~94 (2004), National Academies Press
- Sung Ho Kyung, "Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January–May 2020", Journal of Korean Medical Science, 35(30), pp.1~11 (2020), 대한의학회[DOI]
- Kim SR, "Risk factors on the progression to clinical outcomes of COVID-19 patients in South Korea : using national data", Int J Environ Res Public Health, 17, pp.8847~ (2020)
- WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection, "A minimal common outcome measure set for COVID-19 clinical research", Lancet Infect Dis, 20, pp.e192~e197 (2020)
- Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, 77, pp.683~690 (2020)
- Lu R, "Genomic characterisation and epidemiology of 2019 novel coronavirus : implications for virus origins and receptor binding", Lancet, 395, pp.565~574 (2020)
- Hamming I, "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis", J Pathol, 203, pp.631~637 (2004)
- Lippi A, "SARS-CoV-2 : at the crossroad between aging and neurodegeneration", Mov Disord, 35, pp.716~720 (2020)
- López-Valdés HE, "The role of neuroinflammation in age-related dementias", Rev Invest Clin, 68, pp.40~48 (2016)
- Pasqualetti G, "The role of neuroinflammation in dementias", Curr Neurol Neurosci Rep, 15, pp.17~ (2015)
- Moser JS, "Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses", Influenza Other Respir Viruses, 13, pp.3~9 (2019)
- Soeroto AY, "Effect of increased BMI and obesity on the outcome of COVID-19 adult patients : a systematic review and meta-analysis", Diabetes Metab Syndr, 14, pp.1897~1904 (2020)
- Frasca D, "Influence of obesity on pneumococcus infection risk in the elderly", Front Endocrinol(Lausanne), 10, pp.71~ (2019)
- Connors JM, "COVID-19 and its implications for thrombosis and anticoagulation", Blood, 135, pp.2033~2040 (2020)
- Jiang SQ, "The association between severe COVID-19 and low platelet count : evidence from 31 observational studies involving 7613 participants", Br J Haematol, 190, pp.e29~e33 (2020)
- Soraya GV, "Crucial laboratory parameters in COVID-19diagnosis and prognosis: an updated meta-analysis", Med Clin(Engl Ed), 155, pp.143~151 (2020)
- Matias-Guiu JA, "Death rate due to COVID-19in Alzheimer’s disease and frontotemporal dementia", J Alzheimers Dis, 78, pp.537~541 (2020)